Wednesday, October 18, 2017 1:34:15 PM
Regarding Lonza, I think that would be amazing to have a deal with them. Win-win. I have also wondered why we took 2 years to build a facility that can only make 150k doses, and then not even have them operating to make money when this company clearly needs it. Shoot, that money could have maybe funded a trial, or the building of a larger facility. The new facility in Haifa and its director’s connection to Pluristem is interesting though. We can only hope.
Still no news from Japan in a partnership, trial, or Fukushima results. Nothing has come out and has been stagnant for quite some time.
We also have not yet seen any human data for R18, which would come out of the Phase I trial in HCT. Not have we heard from the NYBC.
Looking back at the previous presentations they’ve put out this year, it reads like nothing more than a list of broken promises. We keep planting seeds but have yet to see a tree. No product approval, no partnership, no contracts or sales, no revenue. Still just one giant research project and if we don’t get off the ground soon I could see this 10 year research project owned by someone else.
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM